Intraoperative, adjuvant treatment of gastric cancer with the trifunctional antibody catumaxomab compared to surgery alone: A phase II study

C. M. Krueger,B. A. Berdov,L. A. Roman,A. V. Luft,P. Lampe,Horst Lindhofer,K. Bartelheim,A. Klein,Markus M. Heiss

Intraoperative, adjuvant treatment of gastric cancer with the trifunctional antibody catumaxomab compared to surgery alone: A phase II study

2008

C. M. Krueger
B. A. Berdov
L. A. Roman
A. V. Luft
P. Lampe
Horst Lindhofer
K. Bartelheim
A. Klein
Markus M. Heiss

15529 Background: Gastric cancer patients (pts) have a high risk of peritoneal recurrence due to disseminated tumor cells after surgery. The trifunctional antibody catumaxomab (anti-EpCAM × anti-CD...

Keywords:

Pathology
Adjuvant
Trifunctional antibody
Cancer
Catumaxomab
Phases of clinical research
Surgery
Medicine
tumor cells

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations